SLXN

Latest SEC Filings & News for SLXN

2 most recent filings and news items mentioning SLXN. Updated every 60 seconds.

Get this data via API — free tier: 10,000 calls/day
curl "https://api.brieftape.com/v1/tickers/SLXN/news?limit=20"

Pull SLXN filings straight into your trading bot, model, or app.

Get an API key — free tier: 10,000 calls/day
RestructuringMay 29, 2026Negative

Silexion Therapeutics executes 1-for-10 reverse stock split effective May 28, 2026

Silexion Therapeutics completed a 1-for-10 reverse share split to maintain compliance with Nasdaq Capital Market minimum bid price listing requirements. The consolidation reduces outstanding shares from approximately 4.07 million to 407,471 issued shares while proportionally incr

View filing at SEC.gov →
RestructuringMay 26, 2026Neutral

Silexion Therapeutics Announces 1-for-10 Reverse Share Split

Silexion Therapeutics completed a 1-for-10 reverse share split effective May 28, 2026, to maintain Nasdaq listing compliance and support its clinical development of SIL-204 for KRAS-driven cancers. The move aims to achieve a higher stock price, reduce volatility, and broaden inve

View filing at SEC.gov →
AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.